{"version":"1.0","provider_name":"United States","provider_url":"https:\/\/www.sightsciences.com\/us","author_name":"admin-dev","author_url":"https:\/\/www.sightsciences.com\/us\/author\/admin-dev\/","title":"Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"4mlZsWcoL4\"><a href=\"https:\/\/www.sightsciences.com\/us\/sight-sciences-defeats-invalidity-challenges\/\">Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.sightsciences.com\/us\/sight-sciences-defeats-invalidity-challenges\/embed\/#?secret=4mlZsWcoL4\" width=\"600\" height=\"338\" title=\"&#8220;Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office&#8221; &#8212; United States\" data-secret=\"4mlZsWcoL4\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.sightsciences.com\/us\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"PDF Version MENLO PARK, Calif., March 30, 2023 (GLOBE NEWSWIRE) &#8212; Sight Sciences, Inc. (Nasdaq: SGHT) (\u201cSight Sciences,\u201d or the \u201cCompany\u201d), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients\u2019 lives, today reported that it defeated all four patent invalidity challenges filed by Alcon and Ivantis in the [&hellip;]","thumbnail_url":"https:\/\/ml.globenewswire.com\/media\/NjE3MGRiMzYtYmRiMy00ZTNhLWJhNTUtM2I5MzE4MDgxZDhjLTEyMjEzMjQ=\/tiny\/Sight-Sciences-Inc-.png"}